Latest News & Updates
Breaking News
11 hours ago
Simantini Singh Deo
Other trending news you may like to read
Serina Therapeutics Strengthens Board With Appointment Of Pharma Executive Farrell Simon
Serina Therapeutics strengthens its Board with the appointment of pharma executive Farrell Simon.
Simantini Singh Deo
FDA Accepts Revolution Medicines’ Daraxonrasib Application For Advanced Pancreatic Cancer Treatment
FDA accepts Revolution Medicines' daraxonrasib application for advanced pancreatic cancer treatment.
Simantini Singh Deo
NexTel Medical Expands Acquisition To Include Island 40 Group In $12.75 Million Deal
NexTel Medical expands acquisition to include Island 40 Group in a $12.75 million deal.
Simantini Singh Deo
Spryte Medical Advances Neuro Imaging Program With First INSYTE Trial Participants
Spryte Medical advances neuro imaging program with first INSYTE trial participants.
Simantini Singh Deo
